Skip to main content

Breadcrumb

  1. Home

NGS-based MRD

Submitted by dana.wresch@ne… on Tue, 07/14/2026 - 13:05
  • Read more about NGS-based MRD

Flow cytometry-based MRD

Submitted by dana.wresch@ne… on Tue, 07/14/2026 - 12:49
  • Read more about Flow cytometry-based MRD

Molecular/minimal residual disease (MRD) solutions

Submitted by dana.wresch@ne… on Tue, 07/14/2026 - 11:25
  • Read more about Molecular/minimal residual disease (MRD) solutions

AACR-2026-Real-world-landscape-of-KMT2A-and-NPM1-variants-and-fusions-in-hematologic-malignancies-2020-2025

Submitted by dana.wresch@ne… on Wed, 07/08/2026 - 15:20
  • Read more about AACR-2026-Real-world-landscape-of-KMT2A-and-NPM1-variants-and-fusions-in-hematologic-malignancies-2020-2025

Rapid identification of comprehensive multi-omic protein and RNA biomarkers on a single FFPE tissue section using a novel integrated nCounter® workflow

Submitted by dana.wresch@ne… on Wed, 07/08/2026 - 15:19
  • Read more about Rapid identification of comprehensive multi-omic protein and RNA biomarkers on a single FFPE tissue section using a novel integrated nCounter® workflow

Metabolic reprogramming in RCC tumors contributes to a dysfunctional immune response and immune exhaustion within the tumor microenvironment

Submitted by dana.wresch@ne… on Wed, 07/08/2026 - 15:19
  • Read more about Metabolic reprogramming in RCC tumors contributes to a dysfunctional immune response and immune exhaustion within the tumor microenvironment

PTEN LDT

Submitted by Anonymous (not verified) on Sun, 07/05/2026 - 16:25
  • Read more about PTEN LDT

PTEN FDA for Prostate Carcinoma

Submitted by Anonymous (not verified) on Sun, 07/05/2026 - 16:25
  • Read more about PTEN FDA for Prostate Carcinoma

AI-Based Detection and Scoring of TROP2 Expression in IHC-Stained NSCLC Specimens

Submitted by dana.wresch@ne… on Mon, 06/29/2026 - 13:46
  • Read more about AI-Based Detection and Scoring of TROP2 Expression in IHC-Stained NSCLC Specimens

Identification of molecular alterations in soft tissue sarcoma patients with combined pan-cancer CGP and bespoke sarcoma fusion detection testing

Submitted by dana.wresch@ne… on Mon, 06/29/2026 - 13:43
  • Read more about Identification of molecular alterations in soft tissue sarcoma patients with combined pan-cancer CGP and bespoke sarcoma fusion detection testing

Pagination

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next
  • Last page Last
Subscribe to